Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units

Anticancer Research

Volumn 28, Issue 3 B, 2008, Pages 1813-1820

  Pasetto, Lara Maria ^a   Falci, Cristina ^a   Rizzo, Elisa ^a   De Salvo, Gian Luca ^a   Gasparini, Giampietro ^b   D'Andrea, Mario ^b   Bajetta, Emilio ^c   Platania, Marco ^c   Alabiso, Oscar ^d   Miraglia, Stefania ^d   Oniga, Francesco ^e   Biason, Rita ^e   Chetrì, Maria Concetta ^f   Fedele, Palma ^f   Massara, Giovanna ^g   Romaniello, Incoronata ^g   Giordano, Monica ^h   Luchena, Giovanna ^h   Buzzi, Franco ⁱ   Ricotta, Riccardo ^j   Siena, Salvatore ^j   Monfardini, Silvio ^a   more..

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c National Institute for Cure and Study of Tumours   (Italy)

^d ASO Maggiore della Carita   (Italy)

^e SS Giovanni e Paolo Hospital   (Italy)

^f PERRINO HOSPITAL   (Italy)

^g OSS Trinita   (Italy)

^h SANT ANNA HOSPITAL   (Italy)

ⁱ S MARIA HOSPITAL   (Italy)

^j OSPEDALE NIGUARDA CA GRANDA   (Italy)

more..

Author keywords

Colon cancer; Elderly; Palliative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; RALTITREXED; UFT;

ADULT; AGED; ALOPECIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTINUOUS INFUSION; DIARRHEA; DRUG TOLERABILITY; FEMALE; HAND FOOT SYNDROME; HUMAN; ITALY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VOMITING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLONIC NEOPLASMS; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; ITALY; LEUCOVORIN; MALE; MEDICAL ONCOLOGY; MITOMYCIN; NEOPLASM STAGING; ONCOLOGY SERVICE, HOSPITAL; ORGANOPLATINUM COMPOUNDS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TEGAFUR; URACIL;

EID: 45949094022     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yellen SB, Cella DF and Leslie WT: Age and clinical decision making in oncology patients. J Natl Cancer Inst 86(23): 1766-1770, 1994.
2. Fratino L, Serraino D, Rossi E, Lonardi S and Monfardini S: Survival of elderly patients with metastatic colorectal cancer is improved by inclusion in phase II trials. IV Meeting of International Society of Geriatric Oncology (SIOG). abstr 74, 2003.
3. Extermann M, Overcash J, Lyman GH, Parr J and Balducci L: Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16: 1582-1587, 1998.
4. Saltz LB, Cox JV and Blanke C: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343: 905-914, 2000.
5. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L and Rougier P: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer. A multicenter randomised trial. Lancet 355: 1041-1047, 2000.
6. Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Le Rol A, Walter S, Adam R, Misset JL and Lévi F: Phase III multicenter randomised trial of oxaliplatin added to chrono-modulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18: 136-147, 2000.
7. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F and Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16): 2938-2947, 2000.
8. Lichtman SM and Skirvin JA: Pharmacology of antineoplastic agents in older cancer patients. Oncology (Huntington) 14: 1743-1755, 2000.
9. Charlson ME, Pompei P, Ales KL and MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383, 1987.
10. Basso U and Monfardini S: Multidimensional geriatric evaluation in elderly cancer patients: a practical approach. Eur J Cancer Care 13: 424-433, 2004.
11. UICC. TNM Classification of Malignant Tumours. Sixth edition. New York: Wiley-Liss 75: 25-35, 2002.
12. Monfardini S. Prescribing anti-cancer drugs in elderly cancer patients. Eur J Cancer 38: 2341-2346, 2002.
13. Andre T, Bensmaine MA, Louvet C, François E, Lucas V, Desseigne F, Beerblock K, Bouché O, Carola E, Merrouche Y, Morvan F, Dupont-André G and de Gramont A: Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17(11): 3560-3568, 1999.
14. Fentiman I, Tirelli U, Monfardini S, Schneider M, Festen J and Cognetti F: Cancer in the elderly: why so badly treated? Lancet 28: 1020-1022, 1990.
15. Satariano WA: Comorbidities and cancer. In: Cancer in the Elderly. Hunter CP, Johnson KA, Muss HB (eds.). New York, NY: Marcel Dekker Inc pp. 477-499, 2000.
16. Repetto L, Fratino L and Audisio RA: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20:494-502, 2002.
17. Extermann M, Overcash J and Lyman GH: Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16: 1582-1587, 1998.